Catalyst Wire Dossier Catalyst Wire Dossier

mecasermin

insulin-like growth factor 1
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for mecasermin, covering 2017-06-22 to 2024-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors [Phase 1, Phase 2]

See pricing